{"id":264,"date":"2014-02-06T16:53:38","date_gmt":"2014-02-06T14:53:38","guid":{"rendered":"https:\/\/mic-site.labiux.com\/uncategorized\/ablv-private-equity-fund-2010-palielina-savu-ipasuma-dalu-grindeks-kapitala-lidz-2266\/"},"modified":"2026-10-06T06:29:22","modified_gmt":"2026-10-06T03:29:22","slug":"ablv-private-equity-fund-2010-palielina-savu-ipasuma-dalu-grindeks-kapitala-lidz-2266","status":"publish","type":"post","link":"https:\/\/farmacija-mic.lv\/en\/ablv-private-equity-fund-2010-palielina-savu-ipasuma-dalu-grindeks-kapitala-lidz-2266\/","title":{"rendered":"&#8220;ABLV Private Equity Fund 2010&#8221; palielina savu \u012bpa\u0161uma da\u013cu &#8220;Grindeks&#8221; kapit\u0101l\u0101 l\u012bdz 22,66%"},"content":{"rendered":"<div class=\"wp-block-labiux-legacy-html legacy-content\">\n<p>&#8220;ABLV&#8221; grup\u0101 ietilpsto\u0161ais priv\u0101to invest\u012bciju fonds &#8220;ABLV Private Equity Fund 2010&#8221; ir palielin\u0101jis savu l\u012bdzdal\u012bbu Latvijas farm\u0101cijas uz\u0146\u0113mum\u0101 AS &#8220;Grindeks&#8221; l\u012bdz 22,66%. L\u012bdz \u0161im &#8220;ABLV Private Equity fund 2010&#8221; pieder\u0113ja 11,38% &#8220;Grindeks&#8221; akciju.<\/p>\n<p>Papildus l\u012bdz \u0161im piedero\u0161aj\u0101m &#8220;Grindeks&#8221; akcij\u0101m fonds ieg\u0101d\u0101jies v\u0113l 1 081 593 akcijas no fondu p\u0101rvaldnieka &#8220;East Capital&#8221; p\u0101rvald\u012btajiem invest\u012bciju fondiem, zi\u0146o &#8220;ABLV Bank&#8221; p\u0101rst\u0101vji.<\/p>\n<p>L\u0113mums par \u0161o dar\u012bjumu tika pie\u0146emts, saskatot lielu AS &#8220;Grindeks&#8221; izaugsmes potenci\u0101lu gan jaunu produktu izstr\u0101des jom\u0101, gan eksporta tirgu apg\u016b\u0161an\u0101.<\/p>\n<p>&#8220;ABLV Private Equity Fund 2010&#8221; ir 100% viet\u0113j\u0101 kapit\u0101la invest\u012bciju fonds, kas veic ieguld\u012bjumus vado\u0161os un perspekt\u012bvos uz\u0146\u0113mumos, k\u013c\u016bstot par stabilu, uzticamu un ilggad\u012bgu finan\u0161u partneri, zi\u0146o fonda p\u0101rst\u0101vji. Fondam pieder kapit\u0101la da\u013cas ar\u012b t\u0101dos uz\u0146\u0113mumos k\u0101 SIA &#8220;Depo DIY&#8221;, SIA &#8220;Orto kl\u012bnika&#8221; un SIA &#8220;Vai\u0146ode Agro Holding&#8221;.<\/p>\n<p>AS &#8220;ABLV Bank&#8221; liel\u0101kajiem akcion\u0101riem &#8211; O\u013cegam Fi\u013cam, Ernestam Bernim un Nikai Bernei uz tie\u0161as un netie\u0161as l\u012bdzdal\u012bbas pamata pieder 86% bankas pamatkapit\u0101la. &#8220;ABLV&#8221; grup\u0101 ietilpst &#8220;ABLV Bank&#8221;, &#8220;ABLV Capital Markets&#8221;, &#8220;ABLV Asset Management&#8221; un citi uz\u0146\u0113mumi.<\/p>\n<p>&#8220;Grindeks&#8221; akcijas tiek kot\u0113tas &#8220;NASDAQ OMX Riga&#8221;. Citi uz\u0146\u0113muma liel\u0101kie akcion\u0101ri ir Kirovs Lipmans ar 33,29% akciju, Anna Lipmane ar 16,69% akciju, &#8220;Skandinaviska Enskilda Banken&#8221; (nomin\u0101la tur\u0113t\u0101js) ar 10,22% akciju, &#8220;&#8221;Swedbank&#8221; AS Clients Account&#8221; (nomin\u0101la tur\u0113t\u0101js) ar 8,71% akciju.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>&#8220;ABLV&#8221; grup\u0101 ietilpsto\u0161ais priv\u0101to invest\u012bciju fonds &#8220;ABLV Private Equity Fund 2010&#8221; ir palielin\u0101jis savu l\u012bdzdal\u012bbu Latvijas farm\u0101cijas uz\u0146\u0113mum\u0101 AS &#8220;Grindeks&#8221; l\u012bdz 22,66%. L\u012bdz \u0161im &#8220;ABLV Private Equity fund 2010&#8221; pieder\u0113ja [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":22241,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"mic_cinema_image":0,"mic_focus":"","mic_cinema_focus":"","footnotes":"","_labiux_rail":0},"categories":[70,76,7],"tags":[160,109],"mic_flag":[],"class_list":["post-264","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-farmacijas-zinas","category-jaunakie-raksti","category-statistika","tag-ablv","tag-grindeks"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.4 - aioseo.com -->\n\t<meta name=\"description\" content=\"&quot;ABLV&quot; grup\u0101 ietilpsto\u0161ais priv\u0101to invest\u012bciju fonds &quot;ABLV Private Equity Fund 2010&quot; ir palielin\u0101jis savu l\u012bdzdal\u012bbu Latvijas farm\u0101cijas uz\u0146\u0113mum\u0101 AS &quot;Grindeks&quot; l\u012bdz 22,66%. L\u012bdz \u0161im &quot;ABLV Private Equity fund 2010&quot; pieder\u0113ja 11,38% &quot;Grindeks&quot; akciju. Papildus l\u012bdz \u0161im piedero\u0161aj\u0101m &quot;Grindeks&quot; akcij\u0101m fonds ieg\u0101d\u0101jies v\u0113l 1 081 593 akcijas no fondu p\u0101rvaldnieka &quot;East Capital&quot; p\u0101rvald\u012btajiem invest\u012bciju fondiem, zi\u0146o\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"admin\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/farmacija-mic.lv\/en\/ablv-private-equity-fund-2010-palielina-savu-ipasuma-dalu-grindeks-kapitala-lidz-2266\/\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.4\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"\u201cABLV Private Equity Fund 2010\u201d palielina savu \u012bpa\u0161uma da\u013cu \u201cGrindeks\u201d kapit\u0101l\u0101 l\u012bdz 22,66% - Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta property=\"og:description\" content=\"&quot;ABLV&quot; grup\u0101 ietilpsto\u0161ais priv\u0101to invest\u012bciju fonds &quot;ABLV Private Equity Fund 2010&quot; ir palielin\u0101jis savu l\u012bdzdal\u012bbu Latvijas farm\u0101cijas uz\u0146\u0113mum\u0101 AS &quot;Grindeks&quot; l\u012bdz 22,66%. L\u012bdz \u0161im &quot;ABLV Private Equity fund 2010&quot; pieder\u0113ja 11,38% &quot;Grindeks&quot; akciju. Papildus l\u012bdz \u0161im piedero\u0161aj\u0101m &quot;Grindeks&quot; akcij\u0101m fonds ieg\u0101d\u0101jies v\u0113l 1 081 593 akcijas no fondu p\u0101rvaldnieka &quot;East Capital&quot; p\u0101rvald\u012btajiem invest\u012bciju fondiem, zi\u0146o\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/farmacija-mic.lv\/en\/ablv-private-equity-fund-2010-palielina-savu-ipasuma-dalu-grindeks-kapitala-lidz-2266\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/ABLV.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/ABLV.png\" \/>\n\t\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t\t<meta property=\"og:image:height\" content=\"546\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2014-02-06T14:53:38+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-10-06T03:29:22+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"\u201cABLV Private Equity Fund 2010\u201d palielina savu \u012bpa\u0161uma da\u013cu \u201cGrindeks\u201d kapit\u0101l\u0101 l\u012bdz 22,66% - Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta name=\"twitter:description\" content=\"&quot;ABLV&quot; grup\u0101 ietilpsto\u0161ais priv\u0101to invest\u012bciju fonds &quot;ABLV Private Equity Fund 2010&quot; ir palielin\u0101jis savu l\u012bdzdal\u012bbu Latvijas farm\u0101cijas uz\u0146\u0113mum\u0101 AS &quot;Grindeks&quot; l\u012bdz 22,66%. L\u012bdz \u0161im &quot;ABLV Private Equity fund 2010&quot; pieder\u0113ja 11,38% &quot;Grindeks&quot; akciju. Papildus l\u012bdz \u0161im piedero\u0161aj\u0101m &quot;Grindeks&quot; akcij\u0101m fonds ieg\u0101d\u0101jies v\u0113l 1 081 593 akcijas no fondu p\u0101rvaldnieka &quot;East Capital&quot; p\u0101rvald\u012btajiem invest\u012bciju fondiem, zi\u0146o\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/ABLV.png\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/ablv-private-equity-fund-2010-palielina-savu-ipasuma-dalu-grindeks-kapitala-lidz-2266\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/statistika\\\/#listItem\",\"name\":\"Statistika\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/statistika\\\/#listItem\",\"position\":2,\"name\":\"Statistika\",\"item\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/statistika\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/ablv-private-equity-fund-2010-palielina-savu-ipasuma-dalu-grindeks-kapitala-lidz-2266\\\/#listItem\",\"name\":\"&#8220;ABLV Private Equity Fund 2010&#8221; palielina savu \\u012bpa\\u0161uma da\\u013cu &#8220;Grindeks&#8221; kapit\\u0101l\\u0101 l\\u012bdz 22,66%\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/ablv-private-equity-fund-2010-palielina-savu-ipasuma-dalu-grindeks-kapitala-lidz-2266\\\/#listItem\",\"position\":3,\"name\":\"&#8220;ABLV Private Equity Fund 2010&#8221; palielina savu \\u012bpa\\u0161uma da\\u013cu &#8220;Grindeks&#8221; kapit\\u0101l\\u0101 l\\u012bdz 22,66%\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/statistika\\\/#listItem\",\"name\":\"Statistika\"}}]},{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/ablv-private-equity-fund-2010-palielina-savu-ipasuma-dalu-grindeks-kapitala-lidz-2266\\\/#newsarticle\",\"name\":\"\\u201cABLV Private Equity Fund 2010\\u201d palielina savu \\u012bpa\\u0161uma da\\u013cu \\u201cGrindeks\\u201d kapit\\u0101l\\u0101 l\\u012bdz 22,66% - Medikamentu Inform\\u0101cijas Centrs\",\"headline\":\"&#8220;ABLV Private Equity Fund 2010&#8221; palielina savu \\u012bpa\\u0161uma da\\u013cu &#8220;Grindeks&#8221; kapit\\u0101l\\u0101 l\\u012bdz 22,66%\",\"author\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/wp-content\\\/uploads\\\/ABLV.png\",\"width\":600,\"height\":546},\"datePublished\":\"2014-02-06T16:53:38+02:00\",\"dateModified\":\"2026-10-06T06:29:22+03:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/ablv-private-equity-fund-2010-palielina-savu-ipasuma-dalu-grindeks-kapitala-lidz-2266\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/ablv-private-equity-fund-2010-palielina-savu-ipasuma-dalu-grindeks-kapitala-lidz-2266\\\/#webpage\"},\"articleSection\":\"Farm\\u0101cija, Jaun\\u0101kie raksti, Statistika, ABLV, Grindeks\",\"dateline\":\"Published on February 6, 2014.\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\",\"name\":\"Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Farm\\u0101cijas nozares port\\u0101ls farmaceitiem un \\u0101rstiem. Zi\\u0146as, normat\\u012bvie akti, pas\\u0101kumi un t\\u0101l\\u0101kizgl\\u012bt\\u012bba vienuviet kop\\u0161 2001. gada.\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/ablv-private-equity-fund-2010-palielina-savu-ipasuma-dalu-grindeks-kapitala-lidz-2266\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/be3221a6fac131657111728b4d912a877ec158b123d5db3afef3bd8a59784ece?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"admin\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/ablv-private-equity-fund-2010-palielina-savu-ipasuma-dalu-grindeks-kapitala-lidz-2266\\\/#webpage\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/ablv-private-equity-fund-2010-palielina-savu-ipasuma-dalu-grindeks-kapitala-lidz-2266\\\/\",\"name\":\"\\u201cABLV Private Equity Fund 2010\\u201d palielina savu \\u012bpa\\u0161uma da\\u013cu \\u201cGrindeks\\u201d kapit\\u0101l\\u0101 l\\u012bdz 22,66% - Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"\\\"ABLV\\\" grup\\u0101 ietilpsto\\u0161ais priv\\u0101to invest\\u012bciju fonds \\\"ABLV Private Equity Fund 2010\\\" ir palielin\\u0101jis savu l\\u012bdzdal\\u012bbu Latvijas farm\\u0101cijas uz\\u0146\\u0113mum\\u0101 AS \\\"Grindeks\\\" l\\u012bdz 22,66%. L\\u012bdz \\u0161im \\\"ABLV Private Equity fund 2010\\\" pieder\\u0113ja 11,38% \\\"Grindeks\\\" akciju. Papildus l\\u012bdz \\u0161im piedero\\u0161aj\\u0101m \\\"Grindeks\\\" akcij\\u0101m fonds ieg\\u0101d\\u0101jies v\\u0113l 1 081 593 akcijas no fondu p\\u0101rvaldnieka \\\"East Capital\\\" p\\u0101rvald\\u012btajiem invest\\u012bciju fondiem, zi\\u0146o\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/ablv-private-equity-fund-2010-palielina-savu-ipasuma-dalu-grindeks-kapitala-lidz-2266\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/wp-content\\\/uploads\\\/ABLV.png\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/ablv-private-equity-fund-2010-palielina-savu-ipasuma-dalu-grindeks-kapitala-lidz-2266\\\/#mainImage\",\"width\":600,\"height\":546},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/ablv-private-equity-fund-2010-palielina-savu-ipasuma-dalu-grindeks-kapitala-lidz-2266\\\/#mainImage\"},\"datePublished\":\"2014-02-06T16:53:38+02:00\",\"dateModified\":\"2026-10-06T06:29:22+03:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\",\"name\":\"Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Farm\\u0101cijas nozares port\\u0101ls farmaceitiem un \\u0101rstiem. Zi\\u0146as, normat\\u012bvie akti, pas\\u0101kumi un t\\u0101l\\u0101kizgl\\u012bt\\u012bba vienuviet kop\\u0161 2001. gada.\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"\u201cABLV Private Equity Fund 2010\u201d palielina savu \u012bpa\u0161uma da\u013cu \u201cGrindeks\u201d kapit\u0101l\u0101 l\u012bdz 22,66% - Medikamentu Inform\u0101cijas Centrs","description":"\"ABLV\" grup\u0101 ietilpsto\u0161ais priv\u0101to invest\u012bciju fonds \"ABLV Private Equity Fund 2010\" ir palielin\u0101jis savu l\u012bdzdal\u012bbu Latvijas farm\u0101cijas uz\u0146\u0113mum\u0101 AS \"Grindeks\" l\u012bdz 22,66%. L\u012bdz \u0161im \"ABLV Private Equity fund 2010\" pieder\u0113ja 11,38% \"Grindeks\" akciju. Papildus l\u012bdz \u0161im piedero\u0161aj\u0101m \"Grindeks\" akcij\u0101m fonds ieg\u0101d\u0101jies v\u0113l 1 081 593 akcijas no fondu p\u0101rvaldnieka \"East Capital\" p\u0101rvald\u012btajiem invest\u012bciju fondiem, zi\u0146o","canonical_url":"https:\/\/farmacija-mic.lv\/en\/ablv-private-equity-fund-2010-palielina-savu-ipasuma-dalu-grindeks-kapitala-lidz-2266\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/farmacija-mic.lv\/en\/ablv-private-equity-fund-2010-palielina-savu-ipasuma-dalu-grindeks-kapitala-lidz-2266\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/#listItem","position":1,"name":"Home","item":"https:\/\/farmacija-mic.lv\/en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/statistika\/#listItem","name":"Statistika"}},{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/statistika\/#listItem","position":2,"name":"Statistika","item":"https:\/\/farmacija-mic.lv\/category\/statistika\/","nextItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/ablv-private-equity-fund-2010-palielina-savu-ipasuma-dalu-grindeks-kapitala-lidz-2266\/#listItem","name":"&#8220;ABLV Private Equity Fund 2010&#8221; palielina savu \u012bpa\u0161uma da\u013cu &#8220;Grindeks&#8221; kapit\u0101l\u0101 l\u012bdz 22,66%"},"previousItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/ablv-private-equity-fund-2010-palielina-savu-ipasuma-dalu-grindeks-kapitala-lidz-2266\/#listItem","position":3,"name":"&#8220;ABLV Private Equity Fund 2010&#8221; palielina savu \u012bpa\u0161uma da\u013cu &#8220;Grindeks&#8221; kapit\u0101l\u0101 l\u012bdz 22,66%","previousItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/statistika\/#listItem","name":"Statistika"}}]},{"@type":"NewsArticle","@id":"https:\/\/farmacija-mic.lv\/en\/ablv-private-equity-fund-2010-palielina-savu-ipasuma-dalu-grindeks-kapitala-lidz-2266\/#newsarticle","name":"\u201cABLV Private Equity Fund 2010\u201d palielina savu \u012bpa\u0161uma da\u013cu \u201cGrindeks\u201d kapit\u0101l\u0101 l\u012bdz 22,66% - Medikamentu Inform\u0101cijas Centrs","headline":"&#8220;ABLV Private Equity Fund 2010&#8221; palielina savu \u012bpa\u0161uma da\u013cu &#8220;Grindeks&#8221; kapit\u0101l\u0101 l\u012bdz 22,66%","author":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"publisher":{"@id":"https:\/\/farmacija-mic.lv\/en\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/ABLV.png","width":600,"height":546},"datePublished":"2014-02-06T16:53:38+02:00","dateModified":"2026-10-06T06:29:22+03:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/farmacija-mic.lv\/en\/ablv-private-equity-fund-2010-palielina-savu-ipasuma-dalu-grindeks-kapitala-lidz-2266\/#webpage"},"isPartOf":{"@id":"https:\/\/farmacija-mic.lv\/en\/ablv-private-equity-fund-2010-palielina-savu-ipasuma-dalu-grindeks-kapitala-lidz-2266\/#webpage"},"articleSection":"Farm\u0101cija, Jaun\u0101kie raksti, Statistika, ABLV, Grindeks","dateline":"Published on February 6, 2014."},{"@type":"Organization","@id":"https:\/\/farmacija-mic.lv\/en\/#organization","name":"Medikamentu Inform\u0101cijas Centrs","description":"Farm\u0101cijas nozares port\u0101ls farmaceitiem un \u0101rstiem. Zi\u0146as, normat\u012bvie akti, pas\u0101kumi un t\u0101l\u0101kizgl\u012bt\u012bba vienuviet kop\u0161 2001. gada.","url":"https:\/\/farmacija-mic.lv\/en\/"},{"@type":"Person","@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author","url":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/","name":"admin","image":{"@type":"ImageObject","@id":"https:\/\/farmacija-mic.lv\/en\/ablv-private-equity-fund-2010-palielina-savu-ipasuma-dalu-grindeks-kapitala-lidz-2266\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/be3221a6fac131657111728b4d912a877ec158b123d5db3afef3bd8a59784ece?s=96&d=mm&r=g","width":96,"height":96,"caption":"admin"}},{"@type":"WebPage","@id":"https:\/\/farmacija-mic.lv\/en\/ablv-private-equity-fund-2010-palielina-savu-ipasuma-dalu-grindeks-kapitala-lidz-2266\/#webpage","url":"https:\/\/farmacija-mic.lv\/en\/ablv-private-equity-fund-2010-palielina-savu-ipasuma-dalu-grindeks-kapitala-lidz-2266\/","name":"\u201cABLV Private Equity Fund 2010\u201d palielina savu \u012bpa\u0161uma da\u013cu \u201cGrindeks\u201d kapit\u0101l\u0101 l\u012bdz 22,66% - Medikamentu Inform\u0101cijas Centrs","description":"\"ABLV\" grup\u0101 ietilpsto\u0161ais priv\u0101to invest\u012bciju fonds \"ABLV Private Equity Fund 2010\" ir palielin\u0101jis savu l\u012bdzdal\u012bbu Latvijas farm\u0101cijas uz\u0146\u0113mum\u0101 AS \"Grindeks\" l\u012bdz 22,66%. L\u012bdz \u0161im \"ABLV Private Equity fund 2010\" pieder\u0113ja 11,38% \"Grindeks\" akciju. Papildus l\u012bdz \u0161im piedero\u0161aj\u0101m \"Grindeks\" akcij\u0101m fonds ieg\u0101d\u0101jies v\u0113l 1 081 593 akcijas no fondu p\u0101rvaldnieka \"East Capital\" p\u0101rvald\u012btajiem invest\u012bciju fondiem, zi\u0146o","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/farmacija-mic.lv\/en\/#website"},"breadcrumb":{"@id":"https:\/\/farmacija-mic.lv\/en\/ablv-private-equity-fund-2010-palielina-savu-ipasuma-dalu-grindeks-kapitala-lidz-2266\/#breadcrumblist"},"author":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"creator":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/ABLV.png","@id":"https:\/\/farmacija-mic.lv\/en\/ablv-private-equity-fund-2010-palielina-savu-ipasuma-dalu-grindeks-kapitala-lidz-2266\/#mainImage","width":600,"height":546},"primaryImageOfPage":{"@id":"https:\/\/farmacija-mic.lv\/en\/ablv-private-equity-fund-2010-palielina-savu-ipasuma-dalu-grindeks-kapitala-lidz-2266\/#mainImage"},"datePublished":"2014-02-06T16:53:38+02:00","dateModified":"2026-10-06T06:29:22+03:00"},{"@type":"WebSite","@id":"https:\/\/farmacija-mic.lv\/en\/#website","url":"https:\/\/farmacija-mic.lv\/en\/","name":"Medikamentu Inform\u0101cijas Centrs","description":"Farm\u0101cijas nozares port\u0101ls farmaceitiem un \u0101rstiem. Zi\u0146as, normat\u012bvie akti, pas\u0101kumi un t\u0101l\u0101kizgl\u012bt\u012bba vienuviet kop\u0161 2001. gada.","inLanguage":"en-US","publisher":{"@id":"https:\/\/farmacija-mic.lv\/en\/#organization"}}]},"og:locale":"en_US","og:site_name":"Medikamentu Inform\u0101cijas Centrs","og:type":"article","og:title":"\u201cABLV Private Equity Fund 2010\u201d palielina savu \u012bpa\u0161uma da\u013cu \u201cGrindeks\u201d kapit\u0101l\u0101 l\u012bdz 22,66% - Medikamentu Inform\u0101cijas Centrs","og:description":"&quot;ABLV&quot; grup\u0101 ietilpsto\u0161ais priv\u0101to invest\u012bciju fonds &quot;ABLV Private Equity Fund 2010&quot; ir palielin\u0101jis savu l\u012bdzdal\u012bbu Latvijas farm\u0101cijas uz\u0146\u0113mum\u0101 AS &quot;Grindeks&quot; l\u012bdz 22,66%. L\u012bdz \u0161im &quot;ABLV Private Equity fund 2010&quot; pieder\u0113ja 11,38% &quot;Grindeks&quot; akciju. Papildus l\u012bdz \u0161im piedero\u0161aj\u0101m &quot;Grindeks&quot; akcij\u0101m fonds ieg\u0101d\u0101jies v\u0113l 1 081 593 akcijas no fondu p\u0101rvaldnieka &quot;East Capital&quot; p\u0101rvald\u012btajiem invest\u012bciju fondiem, zi\u0146o","og:url":"https:\/\/farmacija-mic.lv\/en\/ablv-private-equity-fund-2010-palielina-savu-ipasuma-dalu-grindeks-kapitala-lidz-2266\/","og:image":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/ABLV.png","og:image:secure_url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/ABLV.png","og:image:width":600,"og:image:height":546,"article:published_time":"2014-02-06T14:53:38+00:00","article:modified_time":"2026-10-06T03:29:22+00:00","twitter:card":"summary_large_image","twitter:title":"\u201cABLV Private Equity Fund 2010\u201d palielina savu \u012bpa\u0161uma da\u013cu \u201cGrindeks\u201d kapit\u0101l\u0101 l\u012bdz 22,66% - Medikamentu Inform\u0101cijas Centrs","twitter:description":"&quot;ABLV&quot; grup\u0101 ietilpsto\u0161ais priv\u0101to invest\u012bciju fonds &quot;ABLV Private Equity Fund 2010&quot; ir palielin\u0101jis savu l\u012bdzdal\u012bbu Latvijas farm\u0101cijas uz\u0146\u0113mum\u0101 AS &quot;Grindeks&quot; l\u012bdz 22,66%. L\u012bdz \u0161im &quot;ABLV Private Equity fund 2010&quot; pieder\u0113ja 11,38% &quot;Grindeks&quot; akciju. Papildus l\u012bdz \u0161im piedero\u0161aj\u0101m &quot;Grindeks&quot; akcij\u0101m fonds ieg\u0101d\u0101jies v\u0113l 1 081 593 akcijas no fondu p\u0101rvaldnieka &quot;East Capital&quot; p\u0101rvald\u012btajiem invest\u012bciju fondiem, zi\u0146o","twitter:image":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/ABLV.png"},"aioseo_meta_data":{"post_id":"264","title":null,"description":null,"keywords":null,"keyphrases":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_custom_url":null,"og_image_custom_fields":null,"og_image_url":null,"og_image_width":null,"og_image_height":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_image_url":null,"twitter_title":null,"twitter_description":null,"schema_type":"default","schema_type_options":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"limit_modified_date":false,"ai":null,"breadcrumb_settings":null,"seo_analyzer_scan_date":null,"created":"2026-09-22 18:18:29","updated":"2026-10-07 10:45:08"},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/farmacija-mic.lv\/en\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/farmacija-mic.lv\/category\/statistika\/\" title=\"Statistika\">Statistika<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t\u201cABLV Private Equity Fund 2010\u201d palielina savu \u012bpa\u0161uma da\u013cu \u201cGrindeks\u201d kapit\u0101l\u0101 l\u012bdz 22,66%\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/farmacija-mic.lv\/en\/"},{"label":"Statistika","link":"https:\/\/farmacija-mic.lv\/category\/statistika\/"},{"label":"&#8220;ABLV Private Equity Fund 2010&#8221; palielina savu \u012bpa\u0161uma da\u013cu &#8220;Grindeks&#8221; kapit\u0101l\u0101 l\u012bdz 22,66%","link":"https:\/\/farmacija-mic.lv\/en\/ablv-private-equity-fund-2010-palielina-savu-ipasuma-dalu-grindeks-kapitala-lidz-2266\/"}],"_links":{"self":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/264","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/comments?post=264"}],"version-history":[{"count":1,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/264\/revisions"}],"predecessor-version":[{"id":1996,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/264\/revisions\/1996"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/media\/22241"}],"wp:attachment":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/media?parent=264"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/categories?post=264"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/tags?post=264"},{"taxonomy":"mic_flag","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/mic_flag?post=264"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}